A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems

15 Apr 2022

It was a large project that included the following key systems and capabilities:

  • PV Quality – New system implementation to monitor the PV case quality
  • PV Reports Upgrade
    • Implementation of Reporting Rate calculations in disproportionality algorithms based on imported drug sales/patient exposure data
    • EVDAS auto-download utility
  • PV Reports Japan – Two new reports (NUPR, SLL)
  • Tech: Upgrade of Oracle 12C to Oracle 19C